Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by cytochromeon May 10, 2016 3:25pm

98 Views

Post# 24859004

RE:Wave lengths and efficacy

BTW,..are you saying one treatment resulted in improvement of a degenerative joint condition?
If that's true.......I would say a Lancet paper is in order......maybe you can write one??
Otherwise, what the patient is experiencing is reduction of pain via temporary nerve inhibition (read a few Roberta Chow articles for more info).

Bullboard Posts

High-growth stock Happy Belly opens first Rosie's Burgers in Alberta